Skip to main content

Merck

HEADLINE_ROUNDUP

Dreamstime

Headline Roundup

Paxlovid, Pfizer's COVID-19 Pill, May Mix Poorly With Other Common Medications

From the Right
Experts Warn Pfizer Antiviral Pills May Pose Risks With Other Medications

Newsmax (News)

AllSides Media Bias Rating: Right
From the Left
Pfizer antiviral pills may be risky with other medications

NBC News Digital

AllSides Media Bias Rating: Lean Left
From the Center
Pfizer antiviral pill could be risky with other widely used medications

The Hill

AllSides Media Bias Rating: Center
HEADLINE_ROUNDUP

Merck/BBC News

Headline Roundup

UK Becomes First Country To Authorize Use Of Merck's COVID-19 Pill

See how BBC News, The Epoch Times, and Washington Post cover this story.
HEADLINE_ROUNDUP

Mel Evans/AP

Headline Roundup

Merck Asks FDA for Emergency Approval of Antiviral COVID-19 Pill

See how STAT, New York Post (News), and USA TODAY cover this story.
More headline roundups

Balanced News about Merck on AllSides

News from the Left

News from the Center

News from the Right

Experimental mRNA vaccines gain steam with promising cancer trial results

Semafor

AllSides Media Bias Rating: Lean Left
Pfizer antiviral pills may be risky with other medications

NBC News Digital

AllSides Media Bias Rating: Lean Left
Britain authorizes Merck’s molnupiravir, the world’s first approval of oral covid-19 treatment pill

Washington Post

AllSides Media Bias Rating: Lean Left
Merck, Pfizer COVID-19 Antivirals Different From Ivermectin

FactCheck.org

AllSides Media Bias Rating: Lean Left
Drugmakers seek FDA emergency authorization for molnupiravir, antiviral pill to treat COVID-19

USA TODAY

AllSides Media Bias Rating: Lean Left
Merck's promising experimental Covid-19 drug raises hopes for pill to fight virus

Politico

AllSides Media Bias Rating: Lean Left
Merck says experimental pill cuts worst effects of COVID-19

Associated Press

AllSides Media Bias Rating: Lean Left
Red Cross Responds to Latest Tornadoes as Severe Weather Threat Continues

RedCross.org

Political News Media Bias Rating: Not Rated
Merck sues government over drug price negotiation

Roll Call

AllSides Media Bias Rating: Center
Pfizer antiviral pill could be risky with other widely used medications

The Hill

AllSides Media Bias Rating: Center
8 lingering questions about the new Covid pills from Merck and Pfizer

STAT

AllSides Media Bias Rating: Center
First pill to treat Covid gets approval in UK

BBC News

AllSides Media Bias Rating: Center
What we know — and don’t know — about Merck’s new Covid-19 pill

STAT

AllSides Media Bias Rating: Center
Experts Warn Pfizer Antiviral Pills May Pose Risks With Other Medications

Newsmax (News)

AllSides Media Bias Rating: Right
UK Becomes First to Approve Antiviral Home Pill for COVID-19

The Epoch Times

AllSides Media Bias Rating: Lean Right
Merck asks FDA for emergency approval of its antiviral COVID-19 pill

New York Post (News)

AllSides Media Bias Rating: Lean Right
Merck sees promising results in trial of COVID-19 pill, will apply for emergency approval from FDA

Washington Times

AllSides Media Bias Rating: Lean Right
US Spending $1.2 Billion on Merck’s COVID-19 Treatment Is a ‘Waste of Taxpayers’ Money’: Doctor

The Epoch Times

AllSides Media Bias Rating: Lean Right

Balanced News about Merck from Across the Web Powered by Google. Enhanced by AllSides.

AllSides Balanced Search™ gives you recent news from outlets on all sides of the political spectrum so you can get the full picture.